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Enrichment of Early Fetal-Liver Hemopoietic Stem Cells
of the Rat Using Monoclonal Antibodies Against the
Transferrin Receptor, Thy-1, and MRC-OX82
KENNETH CROOK" and SIMON V. HUNT
Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, England
Fetal livers from inbred rat fetuses at 14 days’ gestation were dispersed into a single-cell
suspension by physical disruption and collagenase digestion. Pluripotent stem cells were
characterized and partially purified by a combination of monoclonal antibodies. These
included CD71 (anti-transferrin receptor, MRC-OX26, used for rosetting), Cdw90 (anti-
Thy-1, MRC-OX7), and the newly described MRC-OX82 (reacting with myeloid cells in
peritoneal exudate), employed in FACS sorting. Enrichment was monitored by long-term
reconstitution of lethally irradiated congenic rats genetically distinguishable from the donor
by an allelomorphic variant of the CD45 cell-surface antigen. At intervals from 3 months
to 1 year, lymph-node cells and peritoneal exudate cells were biopsied for analysis by
two-color flow cytometryNone color to determine donor origin, the other to identify Th cell
(CD4+), Tc cell (CD8+), B cell (sIg+ or CD45RC+ ), neutrophil (OX82 + or OX43- ), and
macrophage (OX43+) compartments. The degree of chimaerism was taken as the read out
of stem-cell activity. No significant differentials between lymph-node and peritoneal
exudate chimaerisms were detected in any of the recipients; therefore, the enrichment
procedure revealed only pluripotent cells, not stem cells of restricted potency. All recovered
stem-cell activity was in the OX26(CD71)-negative, OX7(CDw90)-positive, OX82-positive
fraction. In the optimum case, an enrichment of very roughly 200-fold in cell-for-cell
activity was obtained.
Rat bone-marrow colony-forming units in the spleen (CFUs-12) were found to lack the
surface antigens recognized by the monoclonal antibodies CD53 (MRC-OX44), MRC-OX39,
MRC-OX59, and 144.2.15. These would provide a strategy for their enrichment by
depletion.
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INTRODUCTION
It has long been known that fetal-liver stem cells
differ from adult bone-marrow stem cells (Micklem
and Loutit, 1966; Micklem et al., 1972; Hunt and
Fowler, 1981). In competitive repopulation experi-
ments, the fetal-liver cells always made the major,
and continuously increasing, contribution to the
eventual phenotype, even with excess marrow cells
(Micklem et al., 1972). Therefore, there may be a
surface antigenic distinction between these two cell
types, because, whether the potency difference is
intrinsic (reflecting a developmentally controlled
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genetic program) or extrinsic (for instance, homing
to a particular microenvironment), it is likely to be
manifest in a surface molecular difference. The use
of cell-surface phenotype, as defined by monoclonal
antibodies, has been the method most exploited to
enrich pluripotent hemopoietic stem cells. It has
provided them virtually pure in the mouse and
human and helped to define stem-cell heterogeneity
better (Spangrude et al., 1988; Szilvassy et al., 1989;
Andrews et al., 1990; Terstappen et al., 1991; Keller,
1992; Uchida et al., 1993; Spangrude, 1994). This
strategy of purification, by comparison with others
(e.g. density centrifugation, Jones et al., 1990; or Rh
123 fluorescence, Bertoncello et al., 1991; Srour et
al., 1991), may in addition provide clues about the
adhesion or signaling characteristics of cell-surface
molecules on stem cells.
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Here we aimed to enrich stem cells from day-14
rat fetal liver by defining their surface phenotype. In
studying the liver at this early stage in organoge-
nesis (about 1 day after it becomes sufficiently
erythroid for naked-eye identification in the rat), the
hierarchy of stem cells may be simpler than at both
later stages such as day 17 studied previously (Hunt,
1979; Jefferies et al., 1985a), and in the adult. At day
14, promyelocytes and prolymphocytes are not yet
evident. To define enrichment of stem-cell activity,
potency in two respects must be measured: (1)
self-renewal and (2) ability to repopulate all he-
mopoietic compartments. As others have empha-
sized (Harrison, 1980; Jordon et al., 1990; Keller and
Snodgrass, 1990), in vivo long-term repopulation
assays satisfy these criteria best. We have used a
refinement of the Hunt and Fowler (1981) long-term
reconstitution assay in irradiated rats, using two
strains as cell host and donor that are congenic for
an allelomorphic variant of the rat RT7 (CD45
equivalent) surface antigen (Newton et al., 1986).
CD45 is expressed on virtually all hemopoietic cells,
so that in the various lympho-myeloid subsets,
host-type and donor-type progeny can be distin-
guished by two-color flow cytometry. By determin-
ing chimaerism by registering the allelic phenotype
of individual cells, rather than that of populations
of cells as is necessary for enzyme polymorphic
markers (e.g., Harrison, 1980; Flake et al., 1986) or
retroviral integration, sites (Dick et al., 1985; Lemis-
chka et al., 1986), no assumptions are necessary
about the constancy of marker expression per cell. A
constant dose of host syngeneic bone-marrow cells
is also given to all rats to provide both a source of
more mature progenitor cells to ensure the survival
of the chimaeras immediately following irradiation,
as well as a standard against which the purified
stem cells can compete. Here, we have used this
assay to measure the reconstitution in vivo for
intervals between 1 and 12 months in the CD4/,
CD8/, and surface Ig
/ lymphoid compartments,
and among macrophage and neutrophil peritoneal
exudate cells.
To characterize surface phenotype, we sought
mAb combinations that would identify a small
proportion of fetal-liver cells that contained all
totipotent stem-cell activity. This would maximize
enrichment of activity. We knew that all such
activity in collagenase-digested single-cell suspen-
sions of day-17 liver was in the Transferrin-receptor
negative (OX26-= CD71-) (Jefferies et al., 1985a)
and Thy-l-positive (OX7 --CDw90/) (Hunt, 1979)
fraction. One aim of the present paper was to
investigate whether this was true also of day-14
liver. In the next step, another mAb was selected
from a panel of 36, which were more or less well
characterized against rat lympho-hemopoietic cell-
surface antigens. This picked out a subset of OX26-
negative day-14 liver cells and was also shown to
react on "stem cells" when screened in a standard
bone-marrow colony-forming-unit assay (fetal liver
would have been preferred, but it does not form
spleen colonies in rats). The single mAb selected for
further analysis of the fetal-liver stem-cell pheno-
type was MRC-OX82, originally described as stain-
ing myeloid cells (Highnam, unpublished). Stem-
cell activity in day-14 fetal liver that had been
depleted of OX26-reactive cells and then had been
sorted by two-color flow cytometry for OX7 and
OX82 was measured in long-term repopulation of
irradiation chimaeras to determine the degree of
enrichment. The lymphoid compartment was sam-
pled in lymph nodes, and the myeloid compartment
in peritoneal washes, of the irradiated hosts.
RESULTS
Purifying OX26-Negative Fetal-Liver Cells
Figure l(a) shows the fluorescence profile of OX26
staining day-14 fetal-liver cells, before and after
rosetting to deplete the OX26-reactive cells. Typi-
cally, 90-95% of fetal liver at this stage was positive
for OX26, compared to approximately 20% at day
17, Jefferies et al., 1985a; rosetting gave OX26-
negative cells over 90% pure. To measure stem-cell
activity in this OX26-negative fraction, various
doses of cells before and after rosetting were injec-
tion into irradiated rats, and T- and B-cell chimae-
risms in peripheral lymph nodes were measured
after 8-12 weeks. The results (Fig. 2) show an
enrichment of activity of about ten fold. This corre-
sponded to the enrichment determined by flow
cytometry, indicating that few stem cells had been
lost in the rosetting step. It was not worth assaying
the activity in the rosette-containing population
because of their contamination by OX26-negatives.
Phenotype of OX-26-Negative Fetal-Liver Cells
To further define and subdivide the OX26-negative
population, a range of monoclonal antibodies was
tested for reactivity on these cells. The antibodiesRAT FETAL-LIVER STEM CELLS 237
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FIGURE 1. (a) Staining of day-14 fetal liver with anti-transferrin-receptor antibody (OX26) and with negative control antibody
(OX21) before and after rosette depletion to remove OX26-positive cells. Percent brighter than the marker: Pre-OX26, 78%; pre-OX21,
0.5%; post-OX26, 0.6%. (b) Staining of OX26-depleted day-14 fetal-liver cells with OX82 and OX44 (CD53) antibodies. Percent
brighter than the marker: OX44, 16.4%; OX82, 9.1%; OX21, 0.8%. In both panels, the fluorescence intensity is logarithmic.
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FIGURE 2. Lymphoid reconstitution of irradiated recipient rats by whole and by OX26- day-14 fetal liver. Donor-derived (RT7b/)
cells also staining positively for either CD4 or for sIg were measured in cervical lymph nodes 8-12 weeks following injection of FL
cells in the standard repopulation assay, competing against 5 x 106 bone-marrow cells. Two to six rats per group. Note the potent
activity of 105 unseparated fetal liver cells, and the comparable activity of 104 OX26-negative cells.238 K. CROOK and S.V. HUNT
could broadly be divided into three categories: those
that did not react detectably with OX26- cells,
namely, OX2, OX3 (MHC Class II), W3/25 (CD4),
OX8 (CD8), OX34 (CD2), OX32 and OX51 (both
CD45RC), OX39 (CD25), OX40, OX42 (CD11b/c);
those that reacted with the majority, viz. OX7 (Thy-
1), OX45 and OX46 (both CD48), 94-47, UB11,
UB12; and those that subdivided the population and
would thus be potentially useful for further enrich-
ment of a stem-cell population. These were OX1
(CD45), OX44 (CD53), OX50 (CD44), W3/13 (leuko-
sialin, CD43), OX41, OX43, OX47, OX82, and some
other poorly characterized mAbs. Some examples of
the fluorescence profiles of each of these mAb cate-
gories are shown in Fig. l(b).
CFUs Assays
Seven mAbs reacting with subpopulations of OX26-
negative fetal liver cells (between 2 and 20% above
background) were used in one-color sorts of young
adult rat bone marrow for CFUs assay (Table 1).
Three types of results were seen: CFUs activity
among only the negatives (OX39, OX59, 144.2.15);
CFUs activity in the positively staining fractions
(OX27, OX82); and instances where CFUs activity
was reduced and not fully returned in either the
positive or negative fractions (OX44, 94.30). Among
the mAbs that did stain CFUs, OX82 was selected
for further study on, fetal liver. This mAb identifies
myeloid cells and stromal elements in a variety of
tissues in the adult. Highnam and Hunt (unpub-
lished) have shown that it labels bone-marrow stem
cells assayed by the long-term repopulation assay in
irradiated hosts. By Western blotting of Brij-96
lysates of bone marrow, it reacts with a molecule
about 35 kD, unreduced (data not shown).
Two-Color FACS Sorts of Fetal Liver for OX26
(Transferrin Receptor) and OX82
Day-14 fetal-liver cell suspensions were rosetted to
deplete OX26-bearing cells as before. The depleted
population was further exposed to a mixture of
biotinylated OX26 with OX82, or, as a control, to
biotinylated OX26 with OX21. Phycoerythrin-
avidin (red) and FITC rabbit anti-mouse Ig (green)
were used as second-stage reagents. Thus, any
residual red-stained cells could be gated out by the
FACS to give essentially 100% pure OX26-negative
cells. Figure l(b) shows the heterogeneous levels of
staining by OX82. OX82-positive and OX82-
negative fractions were tested for their ability to
restore hemopoiesis in irradiated hosts by the long-
term repopulation assay (to beyond 1 year post
reconstitution). The T-cell (CD4/), B-cell (sIg/),
macrophage (OX43
/ ), and neutrophil (OX82
/ com-
partments were analyzed for chimaerism. Both at 3
months, the lymphoid [Fig. 3(a)] and myeloid [Fig.
3(b)], and at 12 months [Fig. 3(c)], the lymphoid,
analyses showed clearly that all the stem-cell activ-
ity was returned in the OX26-OX28 fraction. Over
50% chimaerism was detected from 2700 cells;
therefore, their activity could be equated with that
of at least 5 x 106 bone-marrow cells, if we assume
that unseparated and separated stem cells have
similar reconstitution kinetics. In some case [e.g. in
Fig. 3(b), compare OX21 Dim and Whole FL], minor
loss of activity was noted, for reasons discussed in
Materials and Methods. The level of chimaerism
was similar for all compartments, so there was no
evidence for the separation of a committed stem cell,
even though OX82 recognizes a myeloid-restricted
antigen (in the Discussion, the possibility is consid-
ered that this procedure simultaneously copurifies
two or more committed stem cells rather than one
pluripotent stem cell, and is rejected as being un-
likely). The control sort with OX21 yielded all
activity in the negative fraction, as expected. This
whole experiment was repeated twice more, with
entirely similar results.
The approximate factor of enrichment of stem-cell
activity was derived from a comparison of the
number of cells from the initial unsorted population
and from the sorted OX26-OX82 fraction that
were able to produce equivalent chimaerisms. In the
TABLE
Day-12 CFUs Activity in Bone-Marrow Fractions Sorted by FACS
mAB OX39 OX59 144.2.15 OX44 94.30 OX27 OX82
Specificity CD25" IL-2R Ig Unknown CD53 Unknown MHC Class Unknown
CFUs: Dim 16 + 6 31 + 6 17+ 14 9 + 7 4.5 + 4 0 0.7 + 0.7
CFUs: Bright 0.5 + 0.7 0.7 + 0.7 + 0.6 1.3 + 1.3 4 + 2 15 17.2 + 4
Unseparated bone gave the following CFUs: 106:21 +__ 9.6; 0.5 106:11.1 2.1; 0.1 106:7 4. These data presented net of background endogenous
CFUs 1). The number of cells injected such that Bright Dim 106, partitioned according to the FACS-determined percentage in each fraction. Data given
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[] CD4 T cells
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OX82 Dim OX82 Bright OX21 Dim OX21 Bright
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FIGURE 3. Donor-derived chi-
maerism in peripheral lymph
nodes at 3 months following re-
constitution with fractions of fetal
liver 2-color sorted for OX26 and
OX82. T cells were identified by
staining with the anti-CD4 mAb
W3/25, and B cells by the anti-
mIg mAb OX12. "Whole FL" de-
notes unseparated fetal-liver cells;
"OX82 Dim" and "Bright" refer to
the cells falling respectively into
the negative and positive FACS
sorting gates; "OX21 Dim" and
"Bright" were the equivalent pop-
ulations for the OX21 control sort;
"OX26- FL" refers to cells that
had been rosette-depleted, but
that were not sorted; "PVG BM"
refers to rats that received only a
dose of 5 x 106 syngeneic (RT7a)
cells, to provide an antibody-
staining negative control. The in-
dicated numbers of cells injected
for each fraction were calculated
as described in Materials and
Methods. Error bars represent one
standard deviation. One to three
rats per group. (b) Donor-derived
chimaerism in peritoneal exudate
cells at 3 months following recon-
stitution. Macrophages were de-
fined by staining with the mAb
OX43, and neutrophils by staining
with the mAb OX82. (c) Donor-
derived chimaerism in peripheral
lymph nodes at 12 months follow-
ing reconstitution. Analysis as in
Fig. 3(a).240 K. CROOK and S.V. HUNT
three experiments, the enrichments were 23-fold,
58-fold, and 218-fold. These results confirm that
day-14, fetal liver contains long-term repopulating
stem cells, all of which lack Transferrin receptor
(OX26), and show that OX82 reacts with all such
stem cells. We then attempted further enrichments
using OX7 (specific for rat Thy-1) because (a) of its
well-established stem-cell reactivity (Goldschneider
et al., 1978; Hunt, 1979) and (b) pilot experiments
showed that it labeled a sub-population of OX82
/
OX26, fetal-liver cells.
Two-Color Sorts for OX82- and OX7-Stained
Cells from OX26-Negative Fetal Liver
Day-14 fetal liver cells were rosette-depleted of
OX26-reactive cells and prepared for sorting as
before except that they were stained with bio-
tinylated OX7 and OX82. Double-positive
OX7
/ OX82 cells were separated from the rest. A
negative control sort separated cells stained with
OX21 for both fluorescein and phycoerythrin using
the same gates. Fluorescein contour plots, showing
sort gates, of both test and control stained popula-
tions for sorting are presented in Fig. 4. In this case,
biopsied hemopoietic tissues were analyzed with a
modified range of subset-specific mAbs, i.e., OX22
(CD45RC-bright B cells), OX8 (CD8), W3/25 (CD4),
and OX43-negative peritoneal exudate (granulo-
cytes). All recovered stem-cell activity, repopulating
all these compartments for over 300 days, was
found in the OX7
/ OX82
/ OX26- population (Fig.
5). In the negative-control sort, no activity was
found in the OX21 fraction, all reconstitution
coming from the cells falling in the dull windows
(not shown). This experiment was performed twice
with similar results. Because the proportion of
OX82
/ OX26- cells that stains with OX7 is about
1/2 to 1/3, the extra enrichment obtainable by
including OX7 is about two- to threefold. Results
from CDw90 staining of rat bone marrow (Gold-
schneider et al., 1978) suggest that further sorting
for the very brightest OX7-staining cells might
improve enrichment even further.
DISCUSSION
In the present work, we have extended the obser-
vations of Jefferies et al., (1985a) describing a lack of
reactivity of the anti-transferrin receptor mono-
clonal antibody OX26 on pluripotent stem cells from
day-17 rat fetal liver, and those of Hunt (1979) and
Highnam (unpublished) showing that OX7 (anti-
Thy-1) and OX82 (anti-myeloid) recognize pluripo-
tent stem cells from adult rat bone marrow. By
combining these three monoclonal antibodies in a
OX82
I13m 1131 113 11B 1134 I13S
OX21
OX7 OX21
FIGURE 4. Sort profiles of cells double positive for OX82 and OX7, or OX21 and OX21 (negative-control staining) on OX26- day-14
fetal-liver cells. Double positives were separated from all other cells by the sort gates indicated by the markers. Cells falling into the
upper right quadrant were 13% and 3.5% for positive- and negative-control sorts, respectively.RAT FETAL-LIVER STEM CELLS 241
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FIGURE 5. Donor-derived chimaerism in peripheral lymph nodes and peritoneal exudate at 10 months following reconstitution with
various fractions of day-14 fetal liver having undergone different purification steps. Notation of fractions as Fig. 3(a). "PRE" refers
to cells that were rosetted to remove OX26-reactive cells and that were exposed to OX7 and OX82 antibodies but were not sorted.
"Dim" are all the sorted cells in the L-shaped segment that were not OX7-OX82 double positives; "Bright" are the sorted cells that
were OX7 OX82 /. For chimaera analysis, lymph-node cells were stained with OX22 (CD45RC-bright on B cells), OX8 (CD8 on Tc
cells), and W3/25 (CD4 on Th cells). Peritoneal cells were stained with OX43 and negative cells designated as neutrophil granulocytes.
The indicated numbers of cells injected for each fraction were calculated as described in Materials and Methods. Error bars represent
one standard deviation. Two to three recipient rats per group.
two-step purification procedure, we have both en-
riched the population of presumptive pluripotent
stem cells within day-14 fetal liver by up to about
200-fold, and demonst,rated for the first time the
expression of these three markers on hemopoietic
tissue at such an early stage in gestation. Cells were
first rosetted to remove almost all of the OX26
cells, and then FACS sorted to purify the OX82
OX7 cells among the remaining OX26-negative
cells. Stem-cell activity was measured by the degree
of hemopoietic repopulation in radiation chimaeras
where host and donor cells express allelomorphi-
cally distinct forms of the rat CD45 molecule (RT7;
Newton et al., 1986). The use of this marker system
has the important advantages that CD45 is ex-
pressed on all mature hemopoietic cells, and that the
allelic difference between the two forms appears to
be immunologically silent (Bell et al., 1989). Using
one monoclonal antibody recognizing the donor
form of CD45, and a second recognizing a cell
subset-specific marker, we have measured levels of
CD45 chimaerism in four of the major hemopoietic
compartments (CD
4+ T lymphocytes and sIg B
lymphocytes, macrophages, and neutrophils). This
is an advance on the assay we have already de-
scribed for lymphopoietic reconstitution (Crook et
al., 1987), and that used by Spangrude et al. (1988).
In our current work, percentage chimaerism in each
of the four compartments measured was essentially
at the same level, suggesting that there had been no
preferential enrichment of a stem cell committed to
one or other lineage. It is theoretically possible that
our procedure enriches several different lineage-
committed stem cells (progenitors) in equal propor-
tions, but we regard this as unlikely: Within every
experiment (Figs. 3a to 3c and data not shown),
repopulation did not vary in any lineage over a
period of 1 year following reconstitution. Split chi-
maerism was not found. If there had been a range of
lineage-committed cells within the reconstituting
population, the degree of their contribution to each
compartment would have varied with time due to
their probable different reconstitution kinetics. The
steadiness of the chimaerism at all times postrepop-
ulation is more simply interpreted as being due to
the action of a single kind of more primitive totipo-
tent stem cell. We conclude that the fetal-liver stem
cell giving rise to mature macrophages, neutrophils,
and CD4 T cells and B cells has the phenotype
OX26- OX82/ OX7
We describe here for the first time the mAb MRC
OX82. This predominantly recognizes neutrophils,242 K. CROOK and S.V. HUNT
as judged by (a) forward and side-scatter flow
cytometric profiles of bone marrow and peripheral
blood (Highnam, Webster; personal communica-
tions), and (b) morphological identification of sorted
positive cells from bone marrow. Now, and in
comparable studies on bone marrow in which we
have demonstrated enrichment of long-term repop-
ulating activity by the OX82-positive fraction (High-
nam, unpublished), we show that this surface
antigen is present not only on mature cells, but also
extends back to presumptive totipotent stem cells.
Immunohistological studies have also shown its
expression on a variety of stromal cell types in a
range of nonhemopoietic tissues (Highnam, unpub-
lished), and Western blotting of Brij-96 bone-
marrow lysates shows reactivity on a molecule of
about 35 kD (unreduced; data not shown). Further
biochemical analyses wil be necessary in order to be
able to suggest human or murine counterparts for
this molecule.
OX26 is specific for the rat transferrin receptor
(CD71), and the significance of the lack of expres-
sion of this molecule on primitive stem cells has
already been discussed by Jefferies et al. (1985a).
OX7 recognizes rat Thy-1 and the expression of this
molecule on hemopoietic stem cells from rat and
mouse is well established (Goldschneider et al.,
1978; Hunt, 1979; Berman and Basch, 1985), mak-
ing it a logical choice to use in association with other
mAbs in stem-cell p.urifications. Here we demon-
strate, by the most reliable assay available for stem
cells, namely, long-term repopulation, for the first
time that this molecule is also expressed on primi-
tive stem cells from day-14 fetal liver in rats.
Purification of stem cells form mouse bone marrow
indicated that these had a low expression of the
Thy-1 molecule (Spangrude et al., 1988).
It might be fruitful to explore in a three-color
system whether the OX7 /OX82 /OX26- popula-
tion can be further subdivided. Possible candidates
suggest themselves from the present studies. Of the
other mAbs we tested that stain a minor subpopu-
lation of OX26- a fetal liver, OX44 (Paterson et al.,
1987a) stains the rat equivalent of the membrane
transport protein CD53 (Amiot, 1990; Angelisov/ et
al., 1990). It was absent from the bone-marrow
CFU-S population, though the balance sheet for
this sort left some CFUs unaccounted for, so a
proportion of marrow stem cells may bear OX44
antigen. MHC Class molecules have been de-
scribed by others to be present on murine hemopoi-
etic stem cells (van den Engh et al., 1980; Visser et
al., 1984), and although we showed here the pres-
ence of Class (as defined by the mAb OX27) on rat
bone-marrow CFU-S (Table 1), several attempts to
extend this to long-term reconstituting stem cells
from rat fetal liver gave equivocal results (data not
shown).
Hemopoietic stem cells derived from fetal liver
have long been known to be intrinsically different
from their adult bone-marrow counterparts. Till et
al. (1964) showed that fetal liver could give rise to
CFUs with a seemingly unlimited potential for
sequential transplantation into new recipients,
whereas bone-marrow-derived CFUs were only
transplantable a few times until no new CFUs were
seen. In addition, fetal-liver-derived CFUs appeared
to contain a higher proportion of morphologically
undifferentiated cells. Subsequent studies looking at
competitive repopulation of irradiated recipients by
bone-marrow and fetal-liver cells similarly showed a
predominance of the latter to reconstitute the he-
mopoietic compartment (Micklem and Loutit, 1966;
Micklem et al., 1972; Hunt and Fowler, 1981). The
reasons for these results are unclear, but it has been
suggested that the more primitive the state of stem
cells, the higher is their potential for self-renewal
(consistent with this, yolk sac cells can be serially
transplanted for longer than fetal-liver cells; Metcalf
and Moore, 1971). It is also possible that the fetal
stem cells have a superior ability to home to the
appropriate hemopoietic microenvironment. The ex-
periments described here confirm these findings, in
that a dose of undepleted fetal-liver cells containing
10 times fewer cells than a dose of bone marrow
injected at the same time repopulated up to 80% of
the hemopoietic compartment after 3 months, and
that this remained constant for more than a year.
Our purification of fetal-liver stem cells at a very
early stage of development should assist in charac-
terizing their developmental programming.
MATERIALS AND METHODS
Animals
PVG RT7 rats were bred under specific pathogen-
free conditions in the MRC Cellular Immunology
Unit, and maintained in a "clean" room (fed on
irradiated meal and acidified water, and air supply
filtered). Congenic PVG RT7
b rats were bred and
maintained under conventional conditions. This
strain was obtained by backcrossing the RT7
b alleleRAT FETAL-LIVER STEM CELLS 243
(as identified by a polyclonal antiserum; Fabre and
Morris, 1974) to PVG inbred rats (RT7a) for twelve
generations (Bell et al., 1989). Skin grafts from the
congenic strain are permanently accepted by normal
PVG RT7 hosts, and T cells from the two strains
show no mutual alloreactivity in vitro or in vivo.
Fetal Liver Preparation
Day-14 fetuses (vaginal plug as day 0) were re-
moved from the mothers (of PVG RT7
b strain) and
washed twice in Dulbecco’s modification of Eagle’s
medium (DMEM), allowing the fetuses fully to
exsanguinate. Livers were dissected out under a
low-power dissection microscope. Digestion of livers
was performed in 0.5 mg/ml collagenase (Type VIII;
Sigma) in DMEM (10 livers/1 ml collagenase) for 30
min at 37C. The mixture was triturated every 10
min to resuspend the larger pieces of tissue that had
settled, as well as to assist in breaking up the livers.
After digestion, the livers were placed on ice and
washed three times in the standard handling me-
dium (Dulbecco’s A + B salts; 10 mM sodium azide
0.1% bovine serum albumin).
Preparation of Lymph-Node and Peritoneal
Exudate Cells
Superficial cervical lymph nodes were biopsied from
anesthetised rats at various times after reconstitu-
tion. The nodes were teased apart with fine forceps,
filtered, and washed in handling medium. For peri-
toneal exudate preparations, rats were injected in-
traperitoneally with 5 ml of a 3% solution of
proteose peptone in phosphate-buffered saline. Six-
teen hours later, 5 ml PBS containing 7.5 units/ml
of heparin were also injected intraperitoneally. The
abdomen was gently massaged and peritoneal exu-
date removed through a hole cut in the abdomen.
This was transferred to a tube with 1 ml of PBS
containing 20 units of heparin. Cells were washed
in handling medium, as before.
Cells derived from both these sources were pre-
pared for two-color flow cytometry, with one anti-
body against a surface molecule specific for a
hemopoietic cell subset (revealed by a second layer
of FITC-conjugated antibody), and the second anti-
body as biotinylated 8G6.1 (revealed by a second
layer of phycoerythrin-avidin) specific for CD45
from the donor-strain rats.
Antibodies
Most of the monoclonal antibodies came from fu-
sions performed within the MRC Cellular Immunol-
ogy Unit: OX7 (anti-rat Thy-1; Mason and Williams,
1980), OX12 (anti-rat kappa light chain; Hunt and
Fowler, 1981), OX21 (anti-human C3b inactivator,
used as a negative control; Hsiung et al., 1982),
OX26 (anti-rat transferrin receptor; Jefferies et al.,
1984), OX27 (anti-rat MHC Class I; Jefferies et al.,
1985b), OX43 (rat macrophage gp85; Robinson et
al., 1986), OX44 (rat CD53 equivalent; Paterson et
al., 1987a), OX48 (Paterson et al., 1987b), W3/15
(glycophorin; Hunt, unpublished), W3/25 (CD4)
(both Williams et al., 1977). All these antibodies
were generous gifts of Dr. A.F. Williams, as were the
other mAbs used in initial phenotyping of OX26-
fetal-liver cells (OX1, OX2, OX3, OX32, OX34,
OX39, OX40, OX41, OX42, OX43, OX45, OX46,
OX47, OX50, OX52, and W3/13). OX82 was pre-
pared in our laboratory following immunization of
mice with anemic rat bone marrow, and was de-
tected by screening normal bone marrow for stain-
ing of cells with light-scatter characteristics of
myeloid cells (Highnam, unpublished). Its myeloid
specificity has been confirmed on peripheral blood
leucocytes (Webster, personal communication), and
by sorting peritoneal exudate populations. Dr. M.
Newton kindly supplied the anti-RT7 monoclonal
antibody, NDS.58 (Newton et al., 1986). The anti-
RT7
b monoclonal antibody, 8G6.1, was a gift of Dr.
D.L. Greiner (Goldschneider et al., 1986). UB11 and
UB12 were a gift from Dr. T. Fukumoto (Fujikara et
al., 1985). The fluorescein-conjugated rabbit F(ab’)2
anti-mouse Ig (F1-RAM) was a kind gift form Dr.
D.W. Mason. The phycoerythrin-avidin conjugate
was generously supplied by Drs. J. Trenear and B.
Roser (Quadrant International, Cambridge).
Rosette Depletion of OX26-Positive Fetal Liver
Cells
Double rosetting (Hunt, 1986) was found to give
rise to a higher yield of OX26-negative cells than
other methods of purification tried (such as panning
or single rosetting), without any loss in purity (data
not shown). Sheep red blood cells (Tissue Culture
Services, Berkshire) were used 2-3 weeks after
bleeding and coated with OX26 IgG using CrC13.
After washing, 1 ml of this preparation was added
to 1 ml of fetal-liver cells (5 x 107 cells/ml). The244 K. CROOK and S.V. HUNT
mixture was rotated at 1 rpm for 20 min at 4C
before addition of a further 1 ml of SRBC conju-
gated as before to the second-layer antibody (rabbit
anti-mouse Ig), followed by a further 5 min rotation
at 4C. The samples were transferred to ice and
rosettes left to settle. Supernatants were removed
after 10 min, and rosettes gently resuspended.
Three supernatants were collected in this way to
recover the maximum number of OX26- cells. Cells
were washed and any contaminating SRBC re-
moved by lysis in isotonic NH4C1 buffer. Purities
were 92+6% (n 6), and recoveries about 50%.
Around 106 cells were recovered from each liver.
CFUs Assays
Bone-marrow cells from PVG rats were stained with
a range of monoclonal antibodies and sorted into
positive and negative populations on the FACS.
Sorted cells at various doses were injected into
irradiated (9.5 Gy at 1 Gy/min, or 12.5 Gy at 0.05
Gy/min) syngeneic rats of 5 weeks in age. Ten to
twelve days later, spleens were removed and fixed
in Bouin’s solution (60% ethanol, 5% acetic acid, 4%
formaldehyde, in water) and macroscopic colonies
on the surface of the spleen counted.
Flow Cytometry
A FACS II (Becton D,ickinson, Mountain View, CA)
upgraded to FACS IV status was used, with Consort
30 acquisition and analysis software. During sorts,
cells were collected in a tube containing 10% bovine
serum albumin. As collected cells were often too few
to count, cell number was estimated from the de-
flections electronically recorded by the FACS.
Radiation Chimaeras
PVG rats (RT7a) of 8-16 weeks of age were whole-
body irradiated with a dose of 9.5 Gy at about 1
Gy/min in a 137Cs Gammacell 40 irradiator (Nor-
dion, formerly Atomic Energy of Canada) at least 4
hr before intravenous injection of cells. Each rat
received a constant dose of 5 x 106 fresh syngeneic
RT7 bone-marrow cells plus RT7
b fetal-liver cells at
the same time. For the fetal liver in some experi-
ments, cells doses for assay of unseparated cells
were determined by titration: Unmanipulated cells
were titrated over three doses, usually at serial
three- or fourfold dilutions. Also, in some experi-
ments, cells that had been exposed to antibody
treatment but not separated were assayed at one of
these doses to determine whether staining itself
affected stem-cell activity. For rosetted and sorted
fractions, cell doses were chosen to measure activity
per fraction (rather than activity per cell) (Hunt,
1986), and were based on numbers of cells recov-
ered after sorting, not on the input cell number. The
sum of the live cell yields after separation (e.g.,
bright plus dull after sorting, either enumerated by
direct counting or calculated from the electronically
identified deflections on the sorter) determined dose
quanta each equal to a particular dose of rosetted
but unsorted cells, usually around 5 x 10 4. Within
an experiment, the stem-cell activity recovered from
the purified fractions was not usually as great as the
starting material. Stem cells unavoidably lost some
activity, particularly during the 4-stage antibody
staining and sorting parts of the protocol, and
electronic counting of sorted fractions probably
overestimated true cell numbers recovered. Sorted
bright and dim fractions were injected in doses
numerically proportional to their recovery numbers
(so that if there were ten-fold more dim than bright,
the assay rats receiving dims received 10 times more
than rats receiving brights) and related to the dose
quantum for rosetted, unsorted cells. The dose
appropriate for whole unseparated fetal liver was
calculated by the numerical enrichment factor,
knowing the numbers of input and of rosette-
depleted cells. No allowance was made for losses of
stem-cell activity caused by cell manipulations, and
activity losses during separation were therefore pre-
sumed to afflict equally all separated fractions and
not to have a differential impact. Each fraction was
normally assayed in triplicate, using three recipient
rats.
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